National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

N-phosphonacetyl-L-aspartate
A stable transition state analogue for an aspartate transcarbamylase- cartalyzed reaction with antineoplastic activity. N-phosphonacetyl-L-aspartate (PALA) is a stable transition analogue of the activated complex for the reaction catalyzed by aspartate transcarbamylase, the first step in the pyrimidine biosynthetic pathway. This agent inhibits de novo pyrimidine biosynthesis and increases the extent to which fluorouracil metabolites are incorporated into RNA. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonym:sparfosate
Abbreviation:PALA



Previous:Mylosar, Mylotarg, Mylovenge, Myochrysine, N-methylformamide
Next:NA17-A antigen, nabilone, nadroparin calcium, NAE inhibitor MLN4924, nafoxidine hydrochloride

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov